General Information of Drug (ID: DMIW227)

Drug Name
INO-3112
Indication
Disease Entry ICD 11 Status REF
Cervical cancer 2C77.0 Phase 1/2 [1]
Head and neck cancer 2D42 Phase 1/2 [2]
Cross-matching ID
TTD ID
D0OA0H
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02172911) A Study of VGX-3100 and INO-9012 DNA Vaccine With Electroporation in Patients With Cervical Cancer. U.S. National Institutes of Health.